Head to Head Contrast: Klotho Neurosciences (KLTO) and Its Rivals
Institutional and Insider Ownership 20.1% of Klotho Neurosciences shares are owned by institutional investors. Comparatively, 50.1% of shares of all “Biological products, except diagnostic” companies are owned by institutional investors. 26.7% of Klotho Neurosciences shares are owned by company insiders. Comparatively, 15.2% of shares of all “Biological products, except diagnostic” companies are owned by company […]
Institutional and Insider Ownership 20.1% of Klotho Neurosciences shares are owned by institutional investors. Comparatively, 50.1% of shares of all “Biological products, except diagnostic” companies are owned by institutional investors. 26.7% of Klotho Neurosciences shares are owned by company insiders. Comparatively, 15.2% of shares of all “Biological products, except diagnostic” companies are owned by company […]
